Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$704,299
+$8,218 QoQ
Shares Held
4,494
-1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#749
of 1,603 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HBK Sorce Advisory LLC holds $60,692,879 across 13 Drug Manufacturers - General names. NVS ranks #11 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,310 | $20,762,135 | |
| 2 | JNJ |
Johnson & Johnson
|
44,818 | $11,382,427 | |
| 3 | MRK |
Merck & Co., Inc.
|
54,037 | $6,943,754 | |
| 4 | ABBV |
AbbVie Inc.
|
20,828 | $5,241,157 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
30,439 | $3,845,663 | |
| 6 | PFE |
Pfizer Inc
|
157,717 | $3,797,825 | |
| 7 | AMGN |
Amgen Inc
|
9,769 | $3,537,550 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
40,142 | $2,312,982 |
All Filings in NVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $704,299 | 4,494 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $696,081 | 4,557 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $601,388 | 4,362 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $440,889 | 3,438 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $376,220 | 3,109 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $291,297 | 2,613 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $227,802 | 2,341 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $264,430 | 2,299 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $268,385 | 2,521 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $229,927 | 2,377 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $246,265 | 2,439 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $246,399 | 2,419 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $241,679 | 2,395 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $214,728 | 2,334 | Shares | Sole | 2023-08-15 | |
| 2022-12-31 | $434,367 | 4,788 | Shares | Sole | 2023-02-09 | |
| 2022-03-31 | $203,580 | 2,320 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $211,589 | 2,419 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $451,752 | 5,524 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $506,017 | 5,546 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $490,227 | 5,735 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $515,304 | 5,457 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $526,542 | 6,055 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $532,511 | 6,097 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $407,467 | 4,942 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||